Retrospective analysis identifies metabolic syndrome as a significant factor in breast nodules, suggesting intervention potential.
Multivariate regression analysis identified MetS [odds ratio (OR) =3.453; 95% confidence interval (CI): 1.569-7.601] and height (OR =1.060 per 1 cm increase, 95% CI: 1.018-1.103) as independent relevant factors. These findings suggest that metabolic health interventions may play an important role in breast nodules.
No takes yet. Share an insight, caveat, or question.
Shen et al. (2026) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: